AAV-Rh.10 Rep-Cap plasmid (serotype Rh.10-specific AAV RC-Rh.10 plasmids) (Amp and Kanamycin) (GeneMedi Owned)

GeneMedi's AAV-Rh.10 Rep-Cap plasmid supplies the AAV2 Rep (replication) proteins and the AAV-Rh.10 capsid protein.

You can produce AAV-Rh.10 particle in 293T cell line in high titer using GeneMedi's AAV-Rh.10 Rep-Cap plasmid with GM's AAV expression vector (overexpression or shRNA) and AAV helper plasmid.

The tissue tropism of AAV-Rh.10 vector has been validated in neuron(CNS), lung, liver, heart and muscle, with potential applications in tissue-specific gene therapy.

GeneMedi offers both Ampicillin (Amp) resistance and Kanamycin (Kan) resistance for the AAV Rep-Cap Plasmids.

Target products collectionGo to AAV vector system >>



Product Description

Cat.NO Product Name Organization Type Price(In USD)
P-RC14 AAV-Rh.10 Rep-Cap Plasmid
Academic 1115
P-RC14 AAV-Rh.10 Rep-Cap Plasmid
Industry R&D
(excluding
CRO&CDMO&CXO)
P-RC14 AAV-Rh.10 Rep-Cap Plasmid
CRO&CDMO&
CXO&CMC&
Manufacturing company
P-RC14-Kan AAV-Rh.10 Rep-Cap Plasmid(Kan resistance)
All
P-PK14 AAV-Rh.10 Vector System
1. AAV-Rh.10 Rep-Cap Plasmid, 5ug
2. AAV Helper Plasmid, 5ug
3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug
Academic 2388
P-PK14 AAV-Rh.10 Vector System
1. AAV-Rh.10 Rep-Cap Plasmid, 5ug
2. AAV Helper Plasmid, 5ug
3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug
Industry R&D
(excluding
CRO&CDMO&CXO)
P-PK14 AAV-Rh.10 Vector System
1. AAV-Rh.10 Rep-Cap Plasmid, 5ug
2. AAV Helper Plasmid, 5ug
3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug
CRO&CDMO&
CXO&CMC&
Manufacturing company
P-PK14-Kan AAV-Rh.10 Vector System(Kan resistance)
1. AAV-Rh.10 Rep-Cap Plasmid(Kan resistance), 10mg
2. AAV Helper Plasmid(Kan resistance), 10mg
3. pGMAAV-CMV-MCS-T2A-ZsGreen (Kan resistance) (P-AAVV-B01-Kan), 10mg
All
GeneMedi offers both seed and amplification services for the Amp-resistant AAV Rep-Cap Plasmid.
GeneMedi only offers amplification services and do not provide seed for the Kan-resistant AAV Rep-Cap Plasmid currently.
If you want to obtain higher quantities of plasmids (mg), please visit GM TransExcellent Plasmid DNA Rapid Preparation Service.
Terms of sale:
For Seed (5ug):
The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for any other party.

For plasmid production&lification (≥10mg):
The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for themselves or any other party.

Citation

Title Publication Date
IFNα Potentiates Anti-PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment Cancer Discovery 2022/4/12
Hypoxia-induced circWSB1 promotes breast cancer progression through destabilizing p53 by interacting with USP10 Molecular Cancer 2022/3/10
Downregulation of MUS81 expression inhibits cell migration and maintains EBV latent infection through miR‐BART9‐5p in EBV‐associated gastric cancer Journal of Medical Virology 2023/4/13
Identification of CircRNA signature associated with tumor immune infiltration to predict therapeutic efficacy of immunotherapy Nature Communications 2023/5/3
PSD?93 up?regulates the synaptic activity of corticotropin?releasing hormone neurons in the paraventricular nucleus in depression Acta Neuropathologica 2021/9/18
NDFIP1 limits cellular TAZ accumulation via exosomal sorting to inhibit NSCLC proliferation Protein & Cell 2022/9/21
The essential role of PRAK in tumor metastasis and its therapeutic potential nature communication 2021/3/19
Two Hippo signaling modules orchestrate liver size and tumorigenesis The EMBO Journal 2023/3/15
[PDF] Development of a rare earth nanoprobe enables in vivo real-time detection of sentinel lymph node metastasis of breast cancer using NIR-IIb imaging Cancer Research 2023/8/4
Bioactive glass nanoparticles inhibit osteoclast differentiation and osteoporotic bone loss by activating lncRNA NRON expression in the extracellular vesicles derived from bone marrow mesenchymal stem cells Biomaterials 2022/2/24


Validation data

No data found


Associated products and services


Products & Service Products & Service Information
AAV Packaging service Detail
Promise-ORF™ viral CDNA library Detail
Plasmid DNA Rapid Preparation Service Detail